Hemostatic patch
Vietnam·Risk Class TTBYT Loại B·Theo theo phụ lục·Tricol Biomedical, Inc.·Registered Aug 21, 2024- Analysis ID
- 240001841/PCBB-HCM
- Submission ID
- 000.00.19.H29-240813-0007
- Product Type
- Theo theo phụ lục
- Product Code
- Theo phụ lục
- Manufacturer
- Tricol Biomedical, Inc.
- Manufacturer Country
- Theo theo phụ lục
- Product Owner
- Tricol Biomedical, Inc.
- Authorized Representative
- CÔNG TY CỔ PHẦN TRANG THIẾT BỊ Y TẾ ĐỨC TÍN
- Intended Use
- The hemostatic patch is indicated for the local management of bleeding wounds and to provide a bacterial barrier of the patch on all patients and to facilitate the rapid control (hemostasis) of the bleeding of patients who have undergone blood transfusion and are being treated with anticoagulant drugs. The patch is indicated for the following types of wounds: skin puncture sites, sites of vascular access procedures and sites including skin puncture, catheter, and needle sites.
- Registration Date
- Aug 21, 2024
Companies providing products similar to "Hemostatic patch"
Recently registered similar products
Access comprehensive regulatory information for Hemostatic patch in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại B medical device is registered under number 240001841/PCBB-HCM and manufactured by Tricol Biomedical, Inc.. The authorized representative in Vietnam is CÔNG TY CỔ PHẦN TRANG THIẾT BỊ Y TẾ ĐỨC TÍN.
This page provides complete technical specifications, regulatory compliance details, 3 companies making similar products including Tricol Biomedical Inc, Aegis Lifesciences Pvt. Ltd., India, and 5 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.